Epitomee Medical Ltd

Tel Aviv Stock Exchange EPIT.TA

Epitomee Medical Ltd Net Income Margin for the year ending December 31, 2023: -56.82%

Epitomee Medical Ltd Net Income Margin is -56.82% for the year ending December 31, 2023. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
SV Wall Street
Tel Aviv Stock Exchange: EPIT.TA

Epitomee Medical Ltd

CEO Dr. Radan Hashimshony Ph.D.
IPO Date Dec. 15, 2021
Location Israel
Headquarters 19 Tarshish
Employees 42
Sector Consumers Staples
Industries
Snack Foods Baby & Childcare Biotechnology Food & Beverages Non-Alcoholic Beverages Pharmaceuticals Soft Drinks & Sodas Vaccines
Description

Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email